Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial

Objectives: The safety and immunogenicity of mammalian cell-derived quadrivalent influenza vaccine (QIVc) as compared with trivalent influenza vaccines (TIV1c/TIV2c) was evaluated in children aged ≥4 to <18 years. Methods: Two thousand three hundred and thirty-three subjects were randomized 2:1:1...

Full description

Bibliographic Details
Main Authors: Robyn Hartvickson, Marilou Cruz, John Ervin, Donald Brandon, Eduardo Forleo-Neto, Alemnew F. Dagnew, Richa Chandra, Kelly Lindert, Ahmed Abdul Mateen
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:International Journal of Infectious Diseases
Subjects:
Influenza
Vaccine
Quadrivalent
Trivalent
Pediatric
MDCK
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971215002647

Internet

http://www.sciencedirect.com/science/article/pii/S1201971215002647

Similar Items